SEC Comment Letter 0000000000-24-004975 to NeuroMetrix, Inc. (NURO) (CIK 0001289850)
NeuroMetrix, Inc. (NURO) (CIK 0001289850)
Date: May 2, 2024 · CIK: 0001289850 · Accession: 0000000000-24-004975
AI Filing Summary & Sentiment
Reasoning
Letter
Re: RS Fund LP NeuroMetrix, Inc. Schedule 13D Filed by RS Fund LP Filed February 26, 2024 File No. 005 -80350 Amendment to the Registration Statement on Form 13D Initial filing number 0001171520 -24-000139
[RUDDY GREGORY LOGO]
Nikhil Cheerharan ncheerharan@ruddylaw.com
1225 15th Street NW • Washington, DC 20005 Telephone (202) 797 -0762 • Fax (202) 318 -0543
March 29, 2024
VIA EDGAR
Division of Corporation Finance Office of Mergers & Acquisitions U.S. Securities Exchange Commission
To the Division of Corporation Finance:
The law firm of Ruddy Gregory, PLLC represents Mr. Ryan Siegal and RS Fund LP. Mr. Siegal and RS Fund LP have revised a prior Schedule 13D filing that was completed for Neurometrix Inc. (Nasdaq: NURO). The initial date of the filing was submitted on February 26, 2024.
The Adjustment Summary is as follows:
• Event date has been a djusted to February 23, 2024. • Box 1 now includes reporting person Mr. Ryan Siegal, the controlling individual. • Item 4 now includes more detail regarding “Purpose of Transaction” and notes the actions that are inapplicable. • Item 5(a) now notes Mr. Ryan Siegal as the beneficial owner of 150,000 shares of NeuroMetrix, Inc., representing 9.9% of the class of sec urities. • Item 5(b) now notes Mr. Ryan Siegal has having the sole pow er to vote or to direct the vote with 150,000 shares and Ryan Siegal sole power to dispose or to direct the disposition of 150,000 shares. Also noted Ryan Siegal percent of class as 9.9%. • Item 5(c) now notes that Mr. Ryan Siegal made the sale on Mar ch 4, 2024; the amount of securities involved were 4,636 shares of Common Stock, for an average price of $4.2574, with the transaction occurring through an open market acquisition.
Should you have any questions or comments, please feel free to contact me telephone at 202-797- 0762 or via email at ncheerharan@ruddylaw.com.
Sincerely,
Nikhil Cheerharan
Show Raw Text
[RUDDY GREGORY LOGO] Nikhil Cheerharan ncheerharan@ruddylaw.com 1225 15th Street NW • Washington, DC 20005 Telephone (202) 797 -0762 • Fax (202) 318 -0543 March 29, 2024 VIA EDGAR Division of Corporation Finance Office of Mergers & Acquisitions U.S. Securities Exchange Commission Re: RS Fund LP NeuroMetrix, Inc. Schedule 13D Filed by RS Fund LP Filed February 26, 2024 File No. 005 -80350 Amendment to the Registration Statement on Form 13D Initial filing number 0001171520 -24-000139 To the Division of Corporation Finance: The law firm of Ruddy Gregory, PLLC represents Mr. Ryan Siegal and RS Fund LP. Mr. Siegal and RS Fund LP have revised a prior Schedule 13D filing that was completed for Neurometrix Inc. (Nasdaq: NURO). The initial date of the filing was submitted on February 26, 2024. The Adjustment Summary is as follows: • Event date has been a djusted to February 23, 2024. • Box 1 now includes reporting person Mr. Ryan Siegal, the controlling individual. • Item 4 now includes more detail regarding “Purpose of Transaction” and notes the actions that are inapplicable. • Item 5(a) now notes Mr. Ryan Siegal as the beneficial owner of 150,000 shares of NeuroMetrix, Inc., representing 9.9% of the class of sec urities. • Item 5(b) now notes Mr. Ryan Siegal has having the sole pow er to vote or to direct the vote with 150,000 shares and Ryan Siegal sole power to dispose or to direct the disposition of 150,000 shares. Also noted Ryan Siegal percent of class as 9.9%. • Item 5(c) now notes that Mr. Ryan Siegal made the sale on Mar ch 4, 2024; the amount of securities involved were 4,636 shares of Common Stock, for an average price of $4.2574, with the transaction occurring through an open market acquisition. Should you have any questions or comments, please feel free to contact me telephone at 202-797- 0762 or via email at ncheerharan@ruddylaw.com. Sincerely, Nikhil Cheerharan